Journal of the Korean Orthopaedic Association (대한정형외과학회지)

Korean Orthopaedic Association (대한정형외과학회)
권호 표지
DOI QR코드

DOI QR Code

Updated Guide to the Treatment of Osteonecrosis of the Femoral Head

대퇴골두 골괴사 치료의 최신 지침

  • Yeom, Ji-Ung (Department of Orthopedic Surgery, Sung-Ae Hospital) ;
  • Kim, Yun-Seong (Department of Orthopedic Surgery, Sung-Ae Hospital) ;
  • Koo, Kyung-Hoi (Department of Orthopedic Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
  • 염지웅 (성애병원 정형외과) ;
  • 김윤성 (성애병원 정형외과) ;
  • 구경회 (서울대학교 의과대학 분당서울대학교병원 정형외과학교실)
  • Received : 2020.07.10
  • Accepted : 2020.11.16
  • Published : 2021.06.30
⟨ Previous Next ⟩

Abstract

Osteonecrosis of the femoral head usually affects young or middle-aged adults and frequently leading to femoral head collapse and hip arthritis. This review reports the updated treatments of the disease.

대퇴골두 골괴사는 젊거나 중년의 성인에서 발생하며 많은 경우에서 대퇴골두의 함몰과 관절염으로 진행된다. 이 종설에서는 이 질환의 치료에 있어 최신 지견을 기술하였다.

Keywords

References

  1. Lafforgue P, Dahan E, Chagnaud C, Schiano A, Kasbarian M, Acquaviva PC. Early-stage avascular necrosis of the femoral head: MR imaging for prognosis in 31 cases with at least 2 years of follow-up. Radiology. 1993;187:199-204. https://doi.org/10.1148/radiology.187.1.8451413
  2. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. 1995;77:459-74. https://doi.org/10.2106/00004623-199503000-00018
  3. Glueck CJ, Freiberg RA, Sieve L, Wang P. Enoxaparin prevents progression of stages I and II osteonecrosis of the hip. Clin Orthop Relat Res. 2005;435:164-70. https://doi.org/10.1097/00003086-200506000-00023
  4. Glueck CJ, Freiberg RA, Wissman R, Wang P. Long term anticoagulation (4-16 years) stops progression of idiopathic hip osteonecrosis associated with familial thrombophilia. Adv Orthop. 2015;2015:138382. https://doi.org/10.1155/2015/138382
  5. Chotanaphuti T, Thongprasert S, Laoruengthana A. Low molecular weight heparin prevents the progression of precollapse osteonecrosis of the hip. J Med Assoc Thai. 2013;96:1326-30.
  6. Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res. 2001;386:173-8. https://doi.org/10.1097/00003086-200105000-00022
  7. Ajmal M, Matas AJ, Kuskowski M, Cheng EY. Does statin usage reduce the risk of corticosteroid-related osteonecrosis in renal transplant population? Orthop Clin North Am. 2009;40:235-9. https://doi.org/10.1016/j.ocl.2009.01.004
  8. U.S. Food and Drug Administration (FDA). FDA Drug Safety Communication: important safety label changes to cholesterol-lowering statin drugs [Internet]. Silver Spring: FDA; 2012 [cited 2019 Jan 7]. Available from: http://www.fda.gov/drugs/drugsafety/ucm293101.htm.
  9. Lai KA, Shen WJ, Yang CY, Shao CJ, Hsu JT, Lin RM. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am. 2005;87:2155-9.
  10. Agarwala S, Sule A, Pai BU, Joshi VR. Alendronate in the treatment of avascular necrosis of the hip. Rheumatology (Oxford). 2002;41:346-7. https://doi.org/10.1093/rheumatology/41.3.346
  11. Nishii T, Sugano N, Miki H, Hashimoto J, Yoshikawa H. Does alendronate prevent collapse in osteonecrosis of the femoral head? Clin Orthop Relat Res. 2006;443:273-9. https://doi.org/10.1097/00003086-200602000-00036
  12. Chen CH, Chang JK, Lai KA, Hou SM, Chang CH, Wang GJ. Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: a two-year multicenter, prospective, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2012;64:1572-8. https://doi.org/10.1002/art.33498
  13. Lee YK, Ha YC, Cho YJ, et al. Does zoledronate prevent femoral head collapse from osteonecrosis? A prospective, randomized, open-label, multicenter study. J Bone Joint Surg Am. 2015;97:1142-8. https://doi.org/10.2106/JBJS.N.01157
  14. Li D, Yang Z, Wei Z, Kang P. Efficacy of bisphosphonates in the treatment of femoral head osteonecrosis: a PRISMA-compliant meta-analysis of animal studies and clinical trials. Sci Rep. 2018;8:1450. https://doi.org/10.1038/s41598-018-19884-z
  15. Yuan HF, Guo CA, Yan ZQ. The use of bisphosphonate in the treatment of osteonecrosis of the femoral head: a meta-analysis of randomized control trials. Osteoporos Int. 2016;27:295-9. https://doi.org/10.1007/s00198-015-3317-5
  16. Pazianas M, Abrahamsen B. Safety of bisphosphonates. Bone. 2011;49:103-10. https://doi.org/10.1016/j.bone.2011.01.003
  17. Jager M, Zilkens C, Bittersohl B, et al. Efficiency of iloprost treatment for osseous malperfusion. Int Orthop. 2011;35:761-5. https://doi.org/10.1007/s00264-010-0998-4
  18. Classen T, Becker A, Landgraeber S, et al. Long-term clinical results after iloprost treatment for bone marrow edema and avascular necrosis. Orthop Rev (Pavia). 2016;8:6150.
  19. Albers A, Carli A, Routy B, Harvey EJ, Seguin C. Treatment with acetylsalicylic acid prevents short to mid-term radiographic progression of nontraumatic osteonecrosis of the femoral head: a pilot study. Can J Surg. 2015;58:198-205. https://doi.org/10.1503/cjs.016814
  20. Chughtai M, Piuzzi NS, Khlopas A, Jones LC, Goodman SB, Mont MA. An evidence-based guide to the treatment of osteonecrosis of the femoral head. Bone Joint J. 2017;99-B:1267-79. https://doi.org/10.1302/0301-620X.99B10.BJJ-2017-0233.R2
  21. Yoon BH, Lee YK, Kim KC, Ha YC, Koo KH. No differences in the efficacy among various core decompression modalities and non-operative treatment: a network meta-analysis. Int Orthop. 2018;42:2737-43. https://doi.org/10.1007/s00264-018-3977-9
  22. Koo KH, Kim R, Ko GH, Song HR, Jeong ST, Cho SH. Preventing collapse in early osteonecrosis of the femoral head. A randomised clinical trial of core decompression. J Bone Joint Surg Br. 1995;77:870-4.
  23. Stulberg BN, Davis AW, Bauer TW, Levine M, Easley K. Osteonecrosis of the femoral head. A prospective randomized treatment protocol. Clin Orthop Relat Res. 1991;268:140-51.
  24. Pierce TP, Elmallah RK, Jauregui JJ, Poola S, Mont MA, Delanois RE. A current review of non-vascularized bone grafting in osteonecrosis of the femoral head. Curr Rev Musculoskelet Med. 2015;8:240-5. https://doi.org/10.1007/s12178-015-9282-y
  25. Mont MA, Etienne G, Ragland PS. Outcome of nonvascularized bone grafting for osteonecrosis of the femoral head. Clin Orthop Relat Res. 2003;417:84-92. https://doi.org/10.1097/01.blo.0000096826.67494.38
  26. Marker DR, Seyler TM, McGrath MS, Delanois RE, Ulrich SD, Mont MA. Treatment of early stage osteonecrosis of the femoral head. J Bone Joint Surg Am. 2008;90 Suppl 4:175-87. https://doi.org/10.2106/JBJS.H.00671
  27. Pierce TP, Jauregui JJ, Elmallah RK, Lavernia CJ, Mont MA, Nace J. A current review of core decompression in the treatment of osteonecrosis of the femoral head. Curr Rev Musculoskelet Med. 2015;8:228-32. https://doi.org/10.1007/s12178-015-9280-0
  28. Kim SY, Kim YG, Kim PT, Ihn JC, Cho BC, Koo KH. Vascularized compared with nonvascularized fibular grafts for large osteonecrotic lesions of the femoral head. J Bone Joint Surg Am. 2005;87:2012-8. https://doi.org/10.2106/00004623-200509000-00015
  29. Plakseychuk AY, Kim SY, Park BC, Varitimidis SE, Rubash HE, Sotereanos DG. Vascularized compared with nonvascularized fibular grafting for the treatment of osteonecrosis of the femoral head. J Bone Joint Surg Am. 2003;85:589-96. https://doi.org/10.2106/00004623-200304000-00001
  30. Vail TP, Urbaniak JR. Donor-site morbidity with use of vascularized autogenous fibular grafts. J Bone Joint Surg Am. 1996;78:204-11. https://doi.org/10.2106/00004623-199602000-00006
  31. Nishio A, Sugioka Y. A new technique of the varus osteotomy at the upper end of the femur. Orthop Traumatol. 1971;20:381-6. https://doi.org/10.5035/nishiseisai.20.381
  32. Ikemura S, Yamamoto T, Jingushi S, Nakashima Y, Mawatari T, Iwamoto Y. Leg-length discrepancy after transtrochanteric curved varus osteotomy for osteonecrosis of the femoral head. J Bone Joint Surg Br. 2007;89:725-9.
  33. Lee YK, Park CH, Ha YC, Kim DY, Lyu SH, Koo KH. Comparison of surgical parameters and results between curved varus osteotomy and rotational osteotomy for osteonecrosis of the femoral head. Clin Orthop Surg. 2017;9:160-8. https://doi.org/10.4055/cios.2017.9.2.160
  34. Sakano S, Hasegawa Y, Torii Y, Kawasaki M, Ishiguro N. Curved intertrochanteric varus osteotomy for osteonecrosis of the femoral head. J Bone Joint Surg Br. 2004;86:359-65.
  35. Zhao G, Yamamoto T, Ikemura S, et al. Radiological outcome analysis of transtrochanteric curved varus osteotomy for osteonecrosis of the femoral head at a mean follow-up of 12.4 years. J Bone Joint Surg Br. 2010;92:781-6.
  36. Sugioka Y. Transtrochanteric anterior rotational osteotomy of the femoral head in the treatment of osteonecrosis affecting the hip: a new osteotomy operation. Clin Orthop Relat Res. 1978;130:191-201.
  37. Tooke SM, Amstutz HC, Hedley AK. Results of transtrochanteric rotational osteotomy for femoral head osteonecrosis. Clin Orthop Relat Res. 1987;224:150-7.
  38. Koo KH, Song HR, Yang JW, Yang P, Kim JR, Kim YM. Trochanteric rotational osteotomy for osteonecrosis of the femoral head. J Bone Joint Surg Br. 2001;83:83-9. https://doi.org/10.1302/0301-620X.83B1.0830083
  39. Ha YC, Kim HJ, Kim SY, Kim KC, Lee YK, Koo KH. Effects of age and body mass index on the results of transtrochanteric rotational osteotomy for femoral head osteonecrosis. J Bone Joint Surg Am. 2010;92:314-21. https://doi.org/10.2106/JBJS.H.01020
  40. Lee YK, Lee B, Parvizi J, Ha YC, Koo KH. Which osteotomy for osteonecrosis of the femoral head and which patient for the osteotomy? Clin Orthop Surg. 2019;11:137-41. https://doi.org/10.4055/cios.2019.11.2.137
  41. Girard J. Is it time for cementless hip resurfacing? HSS J. 2012;8:245-50. https://doi.org/10.1007/s11420-012-9295-7
  42. Mont MA, McGrath MS, Ulrich SD, Seyler TM, Marker DR, Delanois RE. Metal-on-metal total hip resurfacing arthroplasty in the presence of extra-articular deformities or implants. J Bone Joint Surg Am. 2008;90 Suppl 3:45-51. https://doi.org/10.2106/JBJS.H.00436
  43. Purdue PE, Koulouvaris P, Nestor BJ, Sculco TP. The central role of wear debris in periprosthetic osteolysis. HSS J. 2006;2:102-13. https://doi.org/10.1007/s11420-006-9003-6
  44. Ansari F, Ries MD, Pruitt L. Effect of processing, sterilization and crosslinking on UHMWPE fatigue fracture and fatigue wear mechanisms in joint arthroplasty. J Mech Behav Biomed Mater. 2016;53:329-40. https://doi.org/10.1016/j.jmbbm.2015.08.026
  45. Lambert B, Neut D, van der Veen HC, Bulstra SK. Effects of vitamin E incorporation in polyethylene on oxidative degradation, wear rates, immune response, and infections in total joint arthroplasty: a review of the current literature. Int Orthop. 2019;43:1549-57. https://doi.org/10.1007/s00264-018-4237-8
  46. McKee GK. Total hip replacement--past, present and future. Biomaterials. 1982;3:130-5. https://doi.org/10.1016/0142-9612(82)90001-1
  47. Matharu VK, Matharu GS. Metal-on-metal hip replacements: implications for general practice. Br J Gen Pract. 2017;67:544-5. https://doi.org/10.3399/bjgp17x693557
  48. Girard J, Bocquet D, Autissier G, Fouilleron N, Fron D, Migaud H. Metal-on-metal hip arthroplasty in patients thirty years of age or younger. J Bone Joint Surg Am. 2010;92:2419-26. https://doi.org/10.2106/JBJS.I.01644
  49. Eswaramoorthy V, Moonot P, Kalairajah Y, Biant LC, Field RE. The Metasul metal-on-metal articulation in primary total hip replacement: clinical and radiological results at ten years. J Bone Joint Surg Br. 2008;90:1278-83.
  50. Smith AJ, Dieppe P, Howard PW, Blom AW; National Joint Registry for England and Wales. Failure rates of metal-on-metal hip resurfacings: analysis of data from the National Joint Registry for England and Wales. Lancet. 2012;380:1759-66. https://doi.org/10.1016/S0140-6736(12)60989-1
  51. Visuri T, Pukkala E, Paavolainen P, Pulkkinen P, Riska EB. Cancer risk after metal on metal and polyethylene on metal total hip arthroplasty. Clin Orthop Relat Res. 1996;329 Suppl:S280-9. https://doi.org/10.1097/00003086-199608001-00025
  52. The NJR Editorial Board. National Joint Registry (NJR) for England, Wales, Northern Ireland and the Isle of Man. 13th annual report 2016. Hemel Hempstead: NJR; 2016. 182.
  53. Langton DJ, Jameson SS, Joyce TJ, Hallab NJ, Natu S, Nargol AV. Early failure of metal-on-metal bearings in hip resurfacing and large-diameter total hip replacement: a consequence of excess wear. J Bone Joint Surg Br. 2010;92:38-46.
  54. Grammatopoulos G, Pandit H, Kwon YM, et al. Hip resurfacings revised for inflammatory pseudotumour have a poor outcome. J Bone Joint Surg Br. 2009;91:1019-24. https://doi.org/10.1302/0301-620X.91B8.22562
  55. Bala A, Penrose CT, Seyler TM, Randell TR, Wellman SS, Bolognesi MP. Is metal-on-metal total hip arthroplasty associated with neurotoxicity? J Arthroplasty. 2016;31(9 Suppl):233-6.e1. https://doi.org/10.1016/j.arth.2016.03.035
  56. Boutin P. [Total arthroplasty of the hip by fritted aluminum prosthesis. Experimental study and 1st clinical applications]. Rev Chir Orthop Reparatrice Appar Mot. 1972;58:229-46. French.
  57. Mahoney OM, Dimon JH 3rd. Unsatisfactory results with a ceramic total hip prosthesis. J Bone Joint Surg Am. 1990;72:663-71. https://doi.org/10.2106/00004623-199072050-00004
  58. Kang BJ, Ha YC, Ham DW, Hwang SC, Lee YK, Koo KH. Third-generation alumina-on-alumina total hip arthroplasty: 14 to 16-year follow-up study. J Arthroplasty. 2015;30:411-5. https://doi.org/10.1016/j.arth.2014.09.020
  59. Lee YK, Yoon BH, Choi YS, Jo WL, Ha YC, Koo KH. Metal on metal or ceramic on ceramic for cementless total hip arthroplasty: a meta-analysis. J Arthroplasty. 2016;31:2637-45.e1. https://doi.org/10.1016/j.arth.2016.04.014
  60. Kim SC, Lim YW, Jo WL, et al. Fourth-generation ceramic-on-ceramic THA results in improvements in midterm outcomes compared to third-generation THA but does not resolve noise problems: a cohort study of a single-hip system. BMC Musculoskelet Disord. 2019;20:263. https://doi.org/10.1186/s12891-019-2641-x
  61. Hannouche D, Nich C, Bizot P, Meunier A, Nizard R, Sedel L. Fractures of ceramic bearings: history and present status. Clin Orthop Relat Res. 2003;417:19-26. https://doi.org/10.1097/01.blo.0000096806.78689.50
  62. Koo KH, Ha YC, Jung WH, Kim SR, Yoo JJ, Kim HJ. Isolated fracture of the ceramic head after third-generation alumina-on-alumina total hip arthroplasty. J Bone Joint Surg Am. 2008;90:329-36. https://doi.org/10.2106/JBJS.F.01489
  63. Lee YK, Lim JY, Ha YC, Kim TY, Jung WH, Koo KH. Preventing ceramic liner fracture after Delta ceramic-on-ceramic total hip arthroplasty. Arch Orthop Trauma Surg. Published online June 12, 2020; doi:10.1007/s00402-020-03515-2.
  64. Parvizi J, Adeli B, Wong JC, Restrepo C, Rothman RH. A squeaky reputation: the problem may be design-dependent. Clin Orthop Relat Res. 2011;469:1598-605. https://doi.org/10.1007/s11999-011-1777-2